Search for: "State v. Hoffmann" Results 141 - 160 of 296
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2010, 4:07 pm by NL
Since Begum, there has been Tsfayo v United Kingdom 48 EHRR 18. [read post]
5 Mar 2013, 11:03 pm by Aparajita Lath
In true anecdotal style, the author explains the relevance of Section 115 of the Indian statute (appointment of scientific advisors) by pointing out the open expression of gratitude by Lord Hoffmann in Kirin-Amgen v. [read post]
29 Jul 2010, 5:00 am by Bexis
Hoffmann-La Roche Inc., 892 A.2d 694, (N.J. [read post]
7 Sep 2010, 6:10 pm by Kelly
Patent and Trademark Office et. al, (Prior Art) US: District Court New Jersey: Drug label may provide evidence of intent to induce infringement even though required by the FDA: Hoffmann-La Roche Inc. v. [read post]
2 Oct 2008, 12:36 pm
Some states close the causation question at the "I would still prescribe" stage. [read post]
15 Nov 2011, 3:50 am by Rosalind English
And indeed he is not the only person: Lord Hoffmann and Laws LJ are very much on a footing with Sumption here. [read post]
30 Dec 2009, 2:00 am
(EPLAW) Thrombin JM - Pharma company avoids injunction by dropping competitive keyword ads: King v ZymoGenetics (Technology & Marketing Law Blog) Vytorin (Ezetimibe, Simvastatin) - US: Schering files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) Xeloda (Capecitabine) - US: Hoffmann-La Roche files patent infringement complaint against Roxane following Para IV challenge (Patent Docs)   [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US:… [read post]
19 Mar 2014, 9:00 am by Paula Bremner
It has been 15 years since the last brand v brand challenge of a biologic patent in Canada. [read post]
18 Jul 2014, 11:55 am
June. 13, 2013), holding essentially that, since those meanies on the United States Supreme Court aren’t letting plaintiffs sue generic manufacturers, we’ll change Alabama common law and let them sue someone else. [read post]
26 Mar 2014, 3:25 pm
However, the CJEU's decision in Roche v Primus rejected this strategy. [read post]
5 Jul 2010, 10:08 pm by Rosalind English
Along with the contributions of Lord Judge, Lord Hoffmann and Lady Justice Arden, this address forms part of an elegant but increasingly intense debate that reflects unease about Strasbourg. [read post]
19 Apr 2012, 4:44 am by Ronald Podolny
Mere foreseeability of a consequence does not satisfy the requirement of intention: [43] (Lord Hoffmann). [read post]
21 Nov 2011, 5:35 pm by FDABlog HPM
District Court for the District of New Jersey granted a Motion to Dismiss a similar counterclaim in Hoffmann-La Roche Inc. v. [read post]